Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-004495

Director sold 1,270 shares at $17.42 ($22,117)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Heyman Richard A. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-02-15 Sale : show line 1 in the form 10b5-1 −1,270 $17.42 $22,117 144,740 D
Open-market sales · 1,270 sh · avg $17.42 · $22,117
Loading xslF345X05/form4-02212024_120234.xml…